Background: Carotid angioplasty and stenting (CAS) has been introduced as an alternative to carotid endarterectomy for the treatment of carotid atherosclerosis. Due to the risk of embolisation during CAS, the usage of cerebral protection devices is obligatory.
Aim: To assess the safety and efficacy of the novel cerebral protection device -- the MO.MA system.
Methods: Twenty one patients selected for carotid stenting were included into the study. We estimated the deliverability of the device to the target site, procedural success rate and the incidence of adverse events.
Results: All performed procedures were successful without major cerebro-vascular complications during both 30-day and 6-month follow-up periods.
Conclusions: The MO.MA system is safe and effective in preventing stroke during CAS.